837 results on '"Block, Timothy"'
Search Results
2. Pennsylvania Biotechnology Center: A How-to Manual
3. 'Starting It: Why I Started a Life Sciences Incubator'
4. Hepatitis Viruses: Hepatitis B and Hepatitis D
5. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook
6. “PROTAC” modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro
7. Hepatitis Viruses: Hepatitis B and Hepatitis D
8. 3-Sphere Approach on 9-O-(10,11-di-O-benzyl-12,14-O-benzylidene-α-D-galactopyranosyl)-1-butyl-2,3-O-isopropylidene-1,4-dideoxy-1,4-imino-1-<I>N</I>-dehydro-L-ribitol
9. Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study
10. Implications of Circulating Hepatitis B Virus RNA Levels in Assessment of Response to Antiviral Therapy
11. Use of Targeted Glycoproteomics to Identify Serum Glycoproteins That Correlate with Liver Cancer in Woodchucks and Humans
12. Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics
13. Opportunities to address gaps in early detection and improve outcomes of liver cancer
14. Data from The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma
15. Supplementary Tables 1-12 and Figures 1-3 from The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma
16. Imino Sugars Inhibit the Formation and Secretion of Bovine Viral Diarrhea Virus, a Pestivirus Model of Hepatitis C Virus: Implications for the Development of Broad Spectrum Anti-Hepatitis Virus Agents
17. Supplementary Figure 1 from Novel Changes in Glycosylation of Serum Apo-J in Patients with Hepatocellular Carcinoma
18. Supplementary Table and Figures from Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC
19. Supplementary Figure 1 from Increased Levels of Tetra-antennary N-Linked Glycan but Not Core Fucosylation Are Associated with Hepatocellular Carcinoma Tissue
20. Data from Increased Levels of Tetra-antennary N-Linked Glycan but Not Core Fucosylation Are Associated with Hepatocellular Carcinoma Tissue
21. Aberrant Trafficking of Hepatitis B Virus Glycoproteins in Cells in which N-Glycan Processing is Inhibited
22. Hepatitis B Virus (HBV) Envelope Glycoproteins Vary Drastically in their Sensitivity to Glycan Processing: Evidence that Alteration of a Single N-Linked Glycosylation Site can Regulate HBV Secretion
23. Hepatitis Viruses: Hepatitis B and Hepatitis D
24. Elizabethkingia anophelis: Clinical Experience of an Academic Health System in Southeastern Wisconsin
25. Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma
26. Calcium Phosphate Particles as Pulmonary Delivery System for Interferon-α in Mice
27. Overview of Hepatitis Viruses and Cancer
28. An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses
29. A research agenda for curing chronic hepatitis B virus infection
30. Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop
31. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo
32. HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element
33. Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
34. Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
35. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
36. Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system
37. Genetically Engineered Bacteria to Identify and Produce Anti-Viral Agents
38. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care
39. Vascular flora and community assemblages of Delhaas Woods, a coastal plain forest in Bucks County, Pennsylvania
40. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy
41. Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United States
42. The Role of N-Linked Glycosylation in the Secretion of Hepatitis B Virus
43. Role of Glycan Processing in Hepatitis B Virus Envelope Protein Trafficking
44. The hepatitis B epidemic and the urgent need for cure preparedness
45. Vascular Flora and Community Assemblages of Evansburg State Park, Montgomery County, Pennsylvania
46. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
47. A historical perspective on the discovery and elucidation of the hepatitis B virus
48. Glycosylation and Liver Cancer
49. Present and Future Therapies of Hepatitis B: From Discovery to Cure
50. Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.